Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Abstract

Background: Epidemiologic studies of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) have examined different aspects of this disease separately but few have explored them together. Objective: Describe ME/CFS onset and course in one United States-based cohort. Methods: 150 subjects fitting Fukuda 1994 CFS criteria completed a detailed survey concerning the initial and subsequent stages of their illness. Descriptive statistics, graphs, and tables were used to illustrate prevalence and patterns of characteristics. Results: The most common peri-onset events reported by subjects were infection-related episodes (64%), stressful incidents (39%), and exposure to environmental toxins (20%). For 38% of subjects, more than 6 months elapsed from experiencing any initial symptom to developing the set of symptoms comprising their ME/CFS. Over time, the 12 most common symptoms persisted but declined in prevalence, with fatigue, unrefreshing sleep, exertion-related sickness, and flu-like symptoms declining the most (by 20%-25%). Conversely, cognitive symptoms changed the least in prevalence, rising in symptom ranking. Pregnancy, menopause, and menstrual cycles exacerbated many women’s symptoms. Fatigue-related function was not associated with duration of illness or age; during the worst periods of their illness, 48% of subjects could not engage in any productive activity. At the time of survey, 47% were unable to work and only 4% felt their condition was improving steadily with the majority (59%) describing a fluctuating course. Ninety-seven percent suffered from at least one other illness: anxiety (48%), depression (43%), fibromyalgia (39%), irritable bowel syndrome (38%), and migraine headaches (37%) were the most diagnosed conditions. Thirteen percent came from families where at least one other first-degree relative was also afflicted, rising to 27% when chronic fatigue of unclear etiology was included. Conclusions: This paper offers a broad epidemiologic overview of one ME/CFS cohort in the United States. While most of our findings are consistent with prior studies, we highlight underexamined aspects of this condition (e.g. the evolution of symptoms) and propose new interpretations of findings. Studying these aspects can offer insight and solutions to the diagnosis, etiology, pathophysiology, and treatment of this condition.

References 168

1. 1.

   Johnston S Brenu EW Staines D Marshall-Gradisnik S. The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis. Clin Epidemiol. (2013 ) 5:105–10.

   Not in our library10.2147/clep.s39876

2. 2.

   National Academy of Medicine Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Key Facts. National Academy of Sciences, Engineering, Medicine (2015 ). Available online at: https://www.nap.edu/resource/19012/MECFS_KeyFacts.pdf (Accessed August 20, 2018).

   Not in our library

3. 3.

   Jason LA Porter N Brown M Anderson V Brown A Hunnell J. CFS: a review of epidemiology and natural history studies. Bull IACFS ME (2009 ) 17:88–106.

   Not in our library

4. 4.
   Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012 · 2014

   No notice
5. 5.

   Fukuda K Straus SE Hickie I Sharpe MC Dobbins JG Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. (1994 ) 121:953–9.

   Not in our library10.7326/0003-4819-121-12-199412150-00009

6. 6.

   Institute of Medicine (U.S.), Institute of Medicine (U.S.), editors. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press (2015 ).

   Not in our library

7. 7.

   Klimas N Patarca-Montero R Disability and Chronic Fatigue Syndrome: Clinical, Legal, and Patient Perspectives. 1st ed Binghamton, NY: Routledge (1998 ). 124 p.

   Not in our library

8. 8.

   Pendergrast T Brown A Sunnquist M Jantke R Newton JL Strand EB. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. (2016 ) 12:292–307.

   Not in our library10.1177/1742395316644770

9. 9.

   Komaroff AL Fagioli LR Doolittle TH Gandek B Gleit MA Guerriero RT. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med. (1996 ) 101:281–90.

   Not in our library10.1016/s0002-9343(96)00174-x

10. 10.
    The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) · 2015

    No notice
11. 11.

    Núñez M Núñez E del Val JL Fernández-Huerta JM Alegre C Bonet M Health-related quality of life in chronic fatigue syndrome versus rheumatoid arthritis as control group. J Chronic Fatigue Syndr. (2007 ) 14:31–43.

    Not in our library10.1300/j092v14n02_04

12. 12.

    Cairns R Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med. (2005 ) 55:20–31.

    Not in our library10.1093/occmed/kqi013

13. 13.
    The Economic impact of ME/CFS: Individual and societal costs · 2008

    No notice
14. 14.

    Hickie I Davenport T Wakefield D Vollmer-Conna U Cameron B Vernon SD. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006 ) 333:575.

    Not in our library10.1136/bmj.38933.585764.ae

15. 15.

    Katz BZ Shiraishi Y Mears CJ Binns HJ Taylor R Chronic fatigue syndrome following infectious mononucleosis in adolescents: a prospective cohort study. Pediatrics (2009 ) 124:189–93.

    Not in our library10.1542/peds.2008-1879

16. 16.

    Chu L Patient Survey Results for FDA Drug Development Meeting for ME CFS. International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (2013 ). Available online at: http://iacfsme.org/portals/0/pdf/FDA_Survey_Results_Word_Version_July2013%20_2_.pdf (Accessed August 20, 2018).

    Not in our library

17. 17.

    Barrows DM. Functional capacity evaluations of persons with chronic fatigue immune dysfunction syndrome. Am J Occup Ther. (1995 ) 49:327–37.

    Not in our library10.5014/ajot.49.4.327

18. 18.

    Friedberg F Dechene L McKenzie MJ Fontanetta R. Symptom patterns in long-duration chronic fatigue syndrome. J Psychosom Res. (2000 ) 48:59–68.

    Not in our library10.1016/s0022-3999(99)00077-x

19. 19.

    Jason LA. Natural history of chronic fatigue syndrome. Rehabil Psychol. (2011 ) 56:32–42.

    Not in our library10.1037/a0022595

20. 20.

    Tiersky LA DeLuca J Hill N Dhar SK Johnson SK Lange G. Longitudinal assessment of neuropsychological functioning, psychiatric status, functional disability and employment status in chronic fatigue syndrome. Appl Neuropsychol. (2001 ) 8:41–50.

    Not in our library10.1207/s15324826an0801_6

21. 21.

    Nisenbaum R Jones JF Unger ER Reyes M Reeves WC. A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003 ) 1:49.

    Not in our library10.1186/1477-7525-1-49

22. 22.

    Jones DEJ Gray J Frith J Newton JL. Fatigue severity remains stable over time and independently associated with orthostatic symptoms in chronic fatigue syndrome: a longitudinal study. J Intern Med. (2011 ) 269:182–8.

    Not in our library10.1111/j.1365-2796.2010.02306.x

23. 23.

    Nisenbaum R Jones A Jones J Reeves W. Longitudinal analysis of symptoms reported by patients with chronic fatigue syndrome. Ann Epidemiol. (2000 ) 10:458.

    Not in our library10.1016/s1047-2797(00)00119-8

24. 24.

    March D The natural history of chronic fatigue syndrome: evidence from a multi-site clinical epidemiology study. In: Paper Presented at 11th Biennial International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis Conference. San Francisco, CA (2014 ).

    Not in our library

25. 25.

    Endicott NA. Chronic Fatigue Syndrome in Psychiatric Patients: Lifetime and premorbid personal history of physical health. Psychosom Med. (1998 ) 60:744.

    Not in our library10.1097/00006842-199811000-00017

26. 26.

    Dansie EJ Furberg H Afari N Buchwald D Edwards K Goldberg J. Conditions comorbid with chronic fatigue in a population-based sample. Psychosomatics (2012 ) 53:44–50.

    Not in our library10.1016/j.psym.2011.04.001

27. 27.

    Aaron LA Burke MM Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. (2000 ) 160:221–7.

    Not in our library10.1001/archinte.160.2.221

28. 28.

    Aaron LA Herrell R Ashton S Belcourt M Schmaling K Goldberg J. Comorbid clinical conditions in chronic fatigue. J Gen Intern Med. (2001 ) 16:24–31.

    Not in our library10.1046/j.1525-1497.2001.03419.x

29. 29.

    Bateman L Darakjy S Klimas N Peterson D Levine SM Allen A Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue (2015 ) 3:1–15.

    Not in our library10.1080/21641846.2014.978109

30. 30.

    Walsh CM Zainal NZ Middleton SJ Paykel ES. A family history study of chronic fatigue syndrome: Psychiatr Genet. (2001 ) 11:123–8.

    Not in our library10.1097/00041444-200109000-00003

31. 31.

    Torres-Harding SR Jason LA Turkoglu OD Family medical history of persons with chronic fatigue syndrome. J Chronic Fatigue Syndr. (2004 ) 12:25–35.

    Not in our library10.1300/j092v12n04_03

32. 32.

    Njoku N Jason L DiPasqaule L Family Illnesses Among People With ME/CFS: Blood vs. Non-Blood Relatives. Invest in ME (2009 ). Available online at: http://www.investinme.org/documents/journals/Journal%20of%20IiME%20Vol%202%20Issue%202.pdf (Accessed August 20, 2018).

    Not in our library

33. 33.

    Albright F Light K Light A Bateman L Cannon-Albright LA. Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurol. (2011 ) 11:62.

    Not in our library10.1186/1471-2377-11-62

34. 34.

    Pheby D Saffron L Risk factors for severe ME/CFS. Biol Med. (2009 ) 1:50–74.

    Not in our library

35. 35.

    Underhill RA O'gorman R Prevalence of chronic fatigue syndrome and chronic fatigue within families of CFS patients. J Chronic Fatigue Syndr. (2006 ) 13:3–13.

    Not in our library10.1300/j092v13n01_02

36. 36.

    Alegre J Castro-Marrero J Ribases M Alista L Saez N Calvo B Family aggregation studies in CFS. In: Paper presented at 11th Biennial International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Conference. San Francisco, CA (2014 ).

    Not in our library

37. 37.

    Reyes M Nisenbaum R Hoaglin DC Unger ER Emmons C Randall B. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med. (2003 ) 163:1530–6.

    Not in our library10.1001/archinte.163.13.1530

38. 38.
    Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study · 2005

    No notice
39. 39.

    Ruiz E Alegre J García Quintana AM Aliste L Blázquez A Fernández de. [Chronic fatigue syndrome: study of a consecutive series of 824 cases assessed in two specialized units]. Rev Clin Esp. (2011 ) 211:385–90.

    Not in our library10.1016/j.rce.2010.10.007

40. 40.

    Capelli E Lorusso L Ghitti M Venturini L Cusa C Ricevuti G. Chronic fatigue syndrome: features of a population of patients from northern Italy. Int J Immunopathol Pharmacol. (2015 ) 28:53–9.

    Not in our library10.1177/0394632015572074

Cited by papers we hold 4

• Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) · 2023
  No notice
• Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) · 2022
  No notice
• Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology · 2021
  No notice
• Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.